The purpose of the company is to provide services in the field of personalized microbiome banking, the long-term storage of microorganisms, the creation and issuance of microbiome analyses, as well as the blockchain tokenization and licensing of microbial strains, and the research and development of related technologies. Furthermore, the purpose includes the provision of medical-scientific consulting, in particular medical consulting; consulting in the areas of Clinical Operations, Clinical Development, and Medical Affairs; strategic and operational support for companies in the life sciences and healthcare industry (regardless of whether these activities are in the field of the microbiome or in other medical, pharmaceutical, or biotechnological fields), as well as all activities directly or indirectly related thereto. The company may establish branches and subsidiaries in Germany and abroad, participate in other companies in Germany and abroad, and provide financing. The company may acquire, hold, and dispose of real estate in Germany and abroad. It may also provide guarantees and sureties for subsidiaries and third parties.